Thursday, October 9, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Neutral Rating on Equity Residential with Adjusted Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Finance_Assets (2)
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Analyst Vikram Malhorta from Mizuho has decided to keep a Neutral rating on Equity Residential (NYSE:EQR) but has adjusted the price target from $62 to $61 as of February 28, 2024. This change follows a previous increase in the price target from $58 to $62 on January 10, 2024. With a track record of covering 33 stocks and a success rate of 40%, Malhorta’s average return stands at -1.85%. This decision is a result of continuous monitoring and assessment of Equity Residential’s market performance.

Equity Residential (EQR) Stock Performance Review: Positive Price Momentum and After-Hours Gains Signal Potential Growth

On February 28, 2024, Equity Residential (EQR) had a mixed day in terms of stock performance. The stock closed at $59.47, trading in the middle of its 52-week range and below its 200-day simple moving average. Despite this, there were some positive indicators for the stock throughout the day.

One notable aspect of EQR’s performance on February 28 was its price momentum. The stock had a price increase of $0.65 since the market last closed, representing a 1.11% rise. This uptick in price could be seen as a positive sign for investors, indicating potential strength in the stock’s performance.

Additionally, after the market closed, EQR saw a further increase in its stock price. The stock rose by $0.17 in after-hours trading, suggesting continued positive momentum for the stock.

Overall, while EQR may be trading below its 200-day moving average, the price momentum and after-hours trading gains on February 28 indicate that there may be potential for growth in the stock. Investors will likely be keeping a close eye on EQR in the coming days to see if this positive trend continues.

Equity Residential (EQR) Stock Performance Analysis: Positive Growth in Net Income and EPS

On February 28, 2024, Equity Residential (EQR) stock had a mixed performance based on the financial data provided by CNN Money. The company reported total revenue of $2.83 billion for the past year, with a slight increase of 4.7% compared to the previous year. Net income for Equity Residential stood at $835.44 million for the past year, showing a healthy increase of 7.53% since the previous year. The company also reported a significant increase of 80.68% in net income since the last quarter, reaching $311.69 million. Earnings per share (EPS) for Equity Residential were reported at $2.20 for the past year, reflecting a modest increase of 6.96% compared to the previous year. Overall, Equity Residential showed positive growth in net income and earnings per share over the past year, indicating a strong financial performance. However, the flat total revenue and EPS since the last quarter may have had a slight impact on the stock performance on February 28, 2024. Investors and analysts may be monitoring Equity Residential closely to assess its ability to maintain and improve its financial performance in the future. The company’s ability to drive revenue growth and maintain profitability will be key factors influencing its stock performance in the coming quarters.

Tags: EQR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Real Estate Investment Markets and money

Analysts Maintain Neutral Rating on MidAmerica Apartment Communities with Adjusted Price Targets

Finance_Assets (2)

Ambarellas Stock Soars After Exceeding Expectations in Q4 FY24

Finance_Banking (2)

Analyst Updates Rating on Array Technologies to Neutral

Recommended

East West Stock

Strong Q2 Performance at East West Bancorp Amid Insider Trading Activity

2 months ago

Analyst Outlook on Elanco Animal Health Neutral Rating with 18 Price Target

2 years ago
Drones and fishing

Surge in Rail Vision Ltds Stock Price Sparks Investor Interest

2 years ago
Finance_Investment (5)

Hanmi Financial Receives Market Perform Rating with Lowered Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Apple Leadership Transition Gains Momentum as Successor Emerges

Alphabet’s AI Ambitions Face Critical Earnings Test

QuantumScape Shares Surge Amid Strategic Expansion and Upcoming Financial Report

NuScale Power Shares Slide Ahead of Earnings Release

Defense Giant Lockheed Martin Ramps Up Production Amid Global Tensions

Tilray Faces Critical Earnings Test Amid Market Rally

Trending

Bristol-Myers Squibb Stock
Analysis

Bristol-Myers Squibb’s Alzheimer’s Therapy Gains Momentum as Investors Weigh Pipeline Against Patent Cliff

by Dieter Jaworski
October 9, 2025
0

Bristol-Myers Squibb has secured a significant regulatory milestone for its Alzheimer's drug candidate BMS-986446, receiving Fast Track...

Applied Materials Stock

Semiconductor Giant Navigates Geopolitical Crosscurrents

October 9, 2025
Palantir Stock

Security Concerns Rattle Palantir Investors Following Military Report

October 9, 2025
Apple Stock

Apple Leadership Transition Gains Momentum as Successor Emerges

October 9, 2025
Alphabet Stock

Alphabet’s AI Ambitions Face Critical Earnings Test

October 9, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Bristol-Myers Squibb’s Alzheimer’s Therapy Gains Momentum as Investors Weigh Pipeline Against Patent Cliff
  • Semiconductor Giant Navigates Geopolitical Crosscurrents
  • Security Concerns Rattle Palantir Investors Following Military Report

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com